Seeking Alpha
 

Royal DSM NV ADR (RDSMY)

- OTCQX
  • May 3, 2012, 10:50 AM
    Kensey Nash (KNSY) surges 32% to $38.33, nearing the $38.50/share that Royal DSM (RDSMY.PK) is paying for the medical-device company.
    | May 3, 2012, 10:50 AM | Comment!
  • May 3, 2012, 10:14 AM
    Kensey Nash (KNSY): FQ3 EPS of $0.34 misses by $0.01. Revenue of $69.3M (+19.4% Y/Y) in-line. (PR)
    | May 3, 2012, 10:14 AM | Comment!
  • May 3, 2012, 9:00 AM
    Premarket gainers: KNSY +32%. CXW +10%. APKT +7%. ONNN +6%. CLUU +5%. WFM +4%. ARNA +4%. RIG +4%. VIA +3%. TDC +3%. AMT +3%. JRCC +3%. COCO +3%. BUD +3%.
    Losers: GMCR -41%. WTW -15%. ATML -8%. NMM -6%. JDSU -4%. TRS -5%. ARO -4%. HT -4%. M -3%. MGM -3%.
    | May 3, 2012, 9:00 AM | Comment!
  • May 3, 2012, 2:28 AM
    Kensey Nash (KNSY), a medical-device company focused on regenerative medicine, agrees to be bought by Royal DSM (RDSMY.PK) for $38.50/share, more than a 30% premium to Kensey Nash's close yesterday. (PR)
    | May 3, 2012, 2:28 AM | Comment!
  • Mar. 19, 2012, 2:13 PM
    Kensey Nash (KNSY +24%) jumps after saying it's reached a settlement with St. Jude Medical (STJ -0.6%), resolving its dispute regarding vascular closure device licenses and related claims. Under the deal, St. Jude will pay Kensey $39 million over several quarters.
    | Mar. 19, 2012, 2:13 PM | Comment!
  • Feb. 2, 2012, 7:33 AM
    Kensey Nash (KNSY): FQ2 EPS of $0.51 beats by $0.05. Revenue of $23M (+32.2% Y/Y) misses by $0.5M. (PR)
    | Feb. 2, 2012, 7:33 AM | Comment!
  • Dec. 16, 2011, 2:38 PM
    Kensey Nash (KNSY -22%) tanks hard, hitting fresh year lows after saying it is lowering its guidance due to a dispute with St Jude Medical (STJ -1.8%) over royalty rates.
    | Dec. 16, 2011, 2:38 PM | Comment!
  • Dec. 16, 2011, 7:58 AM
    Kensey Nash (KNSY) agrees to enter mediation with St. Jude Medical (STJ) over royalty payments it says it's owed tied to the Angio-Seal vascular closure device. Shares halted premarket.
    | Dec. 16, 2011, 7:58 AM | Comment!
  • Dec. 29, 2009, 5:20 PM
    The quants at Credit Suisse identify 24 Buffett-esque stocks: AFAM, AMGN, APEI, ATRI, AZZ, BKE, BUCY, BYI, CHD, EME, ENSG, JNJ, JOSB, KNSY, LINC, NPK, PETS, POWL, ROST, SCL, TJX, TNDM, VAR, WMS.
    | Dec. 29, 2009, 5:20 PM | 2 Comments
Visit Seeking Alpha's
RDSMY vs. ETF Alternatives
Company Description
DSM "Bright Science. Brighter Living." Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create... More